Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...

Use of avacopan with a lower dose of glucocorticoids leads to fewer total and serious side effects, as well as infections.

Alaska Native and American Indian adults have a high prevalence of AAV, with distinct clinical characteristics and treatment patterns observed.

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

according to late-breaking data presented at the American Academy of Dermatology annual meeting. Increasing wildfire incidence, along with greater overall air pollution, may be contributing to ...

While current clinical practice guidelines recommend the use of either rituximab or cyclophosphamide for the treatment of severe manifestations of systemic vasculitis or connective tissue disease ...

A dermatologist can also perform procedures that may help reduce its appearance. If you have hyperpigmentation, know that you aren’t alone. Hyperpigmentation is a common skin condition ...

The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic inflammatory diseases, Celltrion USA announced in a press release.